OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA
Pasquale Paolisso, Alberto Foà, Luca Bergamaschi, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
Pasquale Paolisso, Luca Bergamaschi, Felice Gragnano, et al.
Pharmacological Research (2022) Vol. 187, pp. 106597-106597
Open Access | Times Cited: 88

Prognostic Relevance of Type 4a Myocardial Infarction and Periprocedural Myocardial Injury in Patients With Non–ST-Segment–Elevation Myocardial Infarction
Matteo Armillotta, Luca Bergamaschi, Pasquale Paolisso, et al.
Circulation (2025)
Closed Access | Times Cited: 6

Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk
Lucia Scisciola, Rosaria Anna Fontanella, Surina Surina, et al.
Life (2021) Vol. 11, Iss. 2, pp. 173-173
Open Access | Times Cited: 102

Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
Nunzia D’Onofrio, Celestino Sardu, Maria Consiglia Trotta, et al.
Molecular Metabolism (2021) Vol. 54, pp. 101337-101337
Open Access | Times Cited: 81

Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA
Pasquale Paolisso, Alberto Foà, Luca Bergamaschi, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 69

Inflammation in Metabolic Cardiomyopathy
Florian A. Wenzl, Samuele Ambrosini, S A Mohammed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 69

Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries
Fuad A. Abdu, Lu Liu, Abdul‐Quddus Mohammed, et al.
European Journal of Internal Medicine (2021) Vol. 92, pp. 79-85
Closed Access | Times Cited: 59

Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
Jamal Majidpoor, Keywan Mortezaee
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112419-112419
Open Access | Times Cited: 57

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
Annamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 53

Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: a systematic review with Bayesian and frequentist meta-analysis
Paschalis Karakasis, Nikolaos Stalikas, Dimitrios Patoulias, et al.
Trends in Cardiovascular Medicine (2023)
Closed Access | Times Cited: 39

Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries
Fuad A. Abdu, Jassur Galip, Penglong Qi, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 30

Characteristics of patients with recurrent acute myocardial infarction after MINOCA
Giuseppe Ciliberti, Federico Guerra, Carmine Pizzi, et al.
Progress in Cardiovascular Diseases (2023) Vol. 81, pp. 42-47
Closed Access | Times Cited: 28

The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways
Luca Bergamaschi, Anna Giulia Pavon, Francesco Angeli, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2083-2083
Open Access | Times Cited: 26

Clinical impact of multimodality assessment of myocardial viability
Lisa Canton, Nicole Suma, Sara Amicone, et al.
Echocardiography (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 9

Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators
Pasquale Paolisso, Luca Bergamaschi, Pietro Rambaldi, et al.
Diabetes Care (2021) Vol. 44, Iss. 9, pp. 2158-2161
Open Access | Times Cited: 51

Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats
Mohammad Raish, Ajaz Ahmad, Yousef A. Bin Jardan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112412-112412
Open Access | Times Cited: 41

Prognostic impact of stress hyperglycemia ratio in acute myocardial infarction patients with and without diabetes mellitus
Jiachen Luo, Siling Xu, Hongqiang Li, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 10, pp. 2356-2366
Closed Access | Times Cited: 23

Systemic proinflammatory−profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome
Hyun‐Jung Lee, Chan Soon Park, Sahmin Lee, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top